Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
J Nephrol. 2013 Mar-Apr;26(2):350-7. doi: 10.5301/jn.5000151. Epub 2012 Jun 7.
A multicenter case-control study on IgA nephropathy (IgAN) was conducted to develop an evidence-based clinicopathologic classification of IgAN for predicting long-term renal outcome.
Two hundred and eighty-seven patients including those with isolated hematuria or very mild proteinuria were enrolled. During a median follow-up of 9.3 years after biopsy, 49 patients (17%) progressed to end stage renal disease (ESRD). The associations between pathological variables and the need for chronic dialysis was examined by multivariate logistic regression analysis separately in patients who required dialysis earlier than 5 years (Early Progressors) and those who required dialysis within 5 to 10 years (Late Progressors) after biopsy.
Independent pathological variables predicting progression to ESRD were global sclerosis, segmental sclerosis and fibrous crescents for Early Progressors, and global sclerosis and cellular/fibrocellular crescents for Late Progressors. Four histological grades, HG 1, HG 2, HG 3 and HG 4, were established corresponding to <25%, 25-49%, 50-74% and =75% of glomeruli exhibiting cellular or fibrocellular crescents, global sclerosis, segmental sclerosis or fibrous crescents. Eleven (7%) patients in HG 1, 12 (16%) in HG 2, 13 (31%) in HG 3 and 13 (68%) in HG 4 progressed to ESRD. Multivariate logistic analysis revealed that the risk of progression to ESRD was significantly higher in HG 2, 3 and 4 than in HG 1 (odds ratio, 2.4, 5.7 and 27.6 vs. 1.0).
Our evidence-based histologic classification can identify the magnitude of the risk of progression to ESRD and is useful for predicting long-term renal outcome in IgAN.
本研究通过多中心病例对照试验对 IgA 肾病(IgAN)进行研究,旨在建立一种基于循证医学的 IgAN 临床病理分类方法,以预测长期肾脏预后。
本研究纳入 287 例患者,包括孤立性血尿或轻度蛋白尿患者。肾活检后中位随访 9.3 年期间,49 例(17%)患者进展至终末期肾病(ESRD)。通过多变量 logistic 回归分析分别检查早期进展患者(透析前 5 年)和晚期进展患者(透析前 5-10 年)的病理变量与需要慢性透析之间的相关性。
独立的病理变量预测早期进展患者进展为 ESRD 的是全球硬化、节段性硬化和纤维性新月体;晚期进展患者则是全球硬化和细胞性/纤维细胞性新月体。根据肾小球中出现细胞性或纤维细胞性新月体、全球硬化、节段性硬化或纤维性新月体的比例,建立了 4 个组织学分级,HG1、HG2、HG3 和 HG4,分别对应<25%、25-49%、50-74%和=75%。HG1 组 11 例(7%)、HG2 组 12 例(16%)、HG3 组 13 例(31%)和 HG4 组 13 例(68%)患者进展为 ESRD。多变量 logistic 分析显示,HG2、3 和 4 组进展为 ESRD 的风险明显高于 HG1 组(优势比,2.4、5.7 和 27.6 与 1.0)。
我们基于证据的组织学分类可以确定进展为 ESRD 的风险程度,并有助于预测 IgAN 的长期肾脏预后。